Industry Analysis & Industry Trends
Although the industry weathered the recession well, the decline in per capita disposable income and fall in the number of people with private health insurance slowed the industry's growth in 2009. In the coming years, the industry will benefit from improving per capita disposable income and a greater number of people with private health insurance. And as couples date and live together longer before marriage, the average age at which couples marry and have children is projected to rise. This trend will ultimately contribute to the industry's growth because older women have a harder time conceiving than younger women do.... purchase to read more
Industry Report - Industry Products Chapter
Artificial reproductive technology treatments
Artificial reproductive technology (ART) treatments are the industry's primary service. The primary method is in-vitro fertilization, which represents more than 99.0% of ART treatments; this segment also includes gamete intrafallopian transfer, zygote intrafallopian transfer, as well as combination treatments. Monitoring for the consideration of such treatments is also included in this segment. ART treatments generate about 77.2% of industry revenue and have increased as a share of revenue since 2013.
ART treatments include procedures that use fresh or frozen embryos. ART treatments with fresh embryos make up about 57.9% of revenue, and ART using frozen embryos generates 19.3% of revenue... purchase to read more